Buller R - Search Results

1

Topotecan in the treatment of elderly patients with relapsed small-cell lung cancer.

Garst J, Buller R, Lane S, Crawford J. Garst J, et al. Among authors: buller r. Clin Lung Cancer. 2005 Nov;7(3):190-6. doi: 10.3816/CLC.2005.n.035. Clin Lung Cancer. 2005. PMID: 16354314

2

Sequential intraperitoneal topotecan and oral etoposide chemotherapy in recurrent platinum-resistant ovarian carcinoma: results of a phase II trial.

Sood AK, Lush R, Geisler JP, Shahin MS, Sanders L, Sullivan D, Buller RE, Sorosky JI. Sood AK, et al. Among authors: buller re. Clin Cancer Res. 2004 Sep 15;10(18 Pt 1):6080-5. doi: 10.1158/1078-0432.CCR-04-0574. Clin Cancer Res. 2004. PMID: 15447993 Clinical Trial.

3

Preservation of the saphenous vein during inguinal lymphadenectomy decreases morbidity in patients with carcinoma of the vulva.

Zhang SH, Sood AK, Sorosky JI, Anderson B, Buller RE. Zhang SH, et al. Among authors: buller re. Cancer. 2000 Oct 1;89(7):1520-5. Cancer. 2000. PMID: 11013366

4

p21 expression predicts outcome in p53-null ovarian carcinoma.

Rose SL, Goodheart MJ, DeYoung BR, Smith BJ, Buller RE. Rose SL, et al. Among authors: buller re. Clin Cancer Res. 2003 Mar;9(3):1028-32. Clin Cancer Res. 2003. PMID: 12631602

5

Radiotherapeutic management of cervical carcinoma that complicates pregnancy.

Sood AK, Sorosky JI, Mayr N, Krogman S, Anderson B, Buller RE, Hussey DH. Sood AK, et al. Among authors: buller re. Cancer. 1997 Sep 15;80(6):1073-8. doi: 10.1002/(sici)1097-0142(19970915)80:6<1073::aid-cncr9>3.0.co;2-a. Cancer. 1997. PMID: 9305707

6

Preoperative serum vascular endothelial growth factor levels: significance in ovarian cancer.

Cooper BC, Ritchie JM, Broghammer CL, Coffin J, Sorosky JI, Buller RE, Hendrix MJ, Sood AK. Cooper BC, et al. Clin Cancer Res. 2002 Oct;8(10):3193-7. Clin Cancer Res. 2002. PMID: 12374688

7

The relationship of molecular markers of p53 function and angiogenesis to prognosis of stage I epithelial ovarian cancer.

Goodheart MJ, Ritchie JM, Rose SL, Fruehauf JP, De Young BR, Buller RE. Goodheart MJ, et al. Among authors: buller re. Clin Cancer Res. 2005 May 15;11(10):3733-42. doi: 10.1158/1078-0432.CCR-04-0056. Clin Cancer Res. 2005. PMID: 15897570

8

The impact of p53 protein core domain structural alteration on ovarian cancer survival.

Rose SL, Robertson AD, Goodheart MJ, Smith BJ, DeYoung BR, Buller RE. Rose SL, et al. Among authors: buller re. Clin Cancer Res. 2003 Sep 15;9(11):4139-44. Clin Cancer Res. 2003. PMID: 14519637

9

Long term follow-up of patients with recurrent ovarian cancer after Ad p53 gene replacement with SCH 58500.

Buller RE, Shahin MS, Horowitz JA, Runnebaum IB, Mahavni V, Petrauskas S, Kreienberg R, Karlan B, Slamon D, Pegram M. Buller RE, et al. Cancer Gene Ther. 2002 Jul;9(7):567-72. doi: 10.1038/sj.cgt.7700473. Cancer Gene Ther. 2002. PMID: 12082456

10

The National Lung Matrix Trial: translating the biology of stratification in advanced non-small-cell lung cancer.

Middleton G, Crack LR, Popat S, Swanton C, Hollingsworth SJ, Buller R, Walker I, Carr TH, Wherton D, Billingham LJ. Middleton G, et al. Among authors: buller r. Ann Oncol. 2015 Dec;26(12):2464-9. doi: 10.1093/annonc/mdv394. Epub 2015 Sep 25. Ann Oncol. 2015. PMID: 26410619 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

419 results

Search Page

Filters